Skip to main content
Premium Trial:

Request an Annual Quote

Philip Beer

OncoDNA has appointed Philip Beer as its medical director in the United Kingdom. In the new position, Beer will review all of OncoDNA's reports and analyses, contacting ordering oncologists to discuss the reports with them. Aside from his new role at OncoDNA, Beer's work includes serving as a molecular and cellular pathologist at a flagship NHS diagnostic unit. He trained as a hematologist at Imperial College, London, and has pursued academic research at the University of Cambridge and the BC Cancer Agency, Vancouver. 

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.